Maaike van der Aa

6PUBLICATIONS
62CO-AUTHORS
Haematological tumoursPacific Peoples theory of change models for healthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 09, 2026
Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes.

Fernando Perez-Villatoro, Aleksandra Shabanova, Lilian van Wagensveld

|Sep 22, 2025
Patient Voices: What Can We Learn From the Covid-19 Pandemic About Follow-Up Care in Gynaecologic Oncology?

Esther M Vermaas, Luc R C W Van Lonkhuijzen, Henrike Westerveld

|Apr 01, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren

|Jan 12, 2024
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting".

Lilian van Wagensveld, Olivier Colomban, Maaike A van der Aa

|Aug 19, 2020
Incidence and predictors of peritoneal metastases of gynecological origin: a population-based study in the Netherlands.

Lara Burg, Maite Timmermans, Maaike van der Aa

|Jan 20, 2020
Short-term surgical complications after radical hysterectomy-A nationwide cohort study.

Hans H B Wenzel, Roy F P M Kruitwagen, Hans W Nijman

Pageof 1

Frequent Collaborators

2 joint publications

Hans H B Wenzel

2 joint publications

Roy F P M Kruitwagen

2 joint publications

Hans W Nijman

2 joint publications

Ruud L M Bekkers